🇲🇾Malaysia·Startups·11 Nov 2026·via New Straits Times

    Indian billionaire, doctors spar over US$900 brain blood-flow tracker Temple

    Doctors have criticized the 'Temple' wearable device, developed by an Indian billionaire entrepreneur, which claims to track blood flow to the brain. The US$900 device, promoted by prominent sportspersons, faces allegations from medical professionals that its core claims are exaggerated, according to a New Straits Times report on November 11, 2026.

    The Temple device, a US$900 wearable, is marketed with the capability to track brain blood flow, a function that implies direct health insights. This commercial offering, developed by an Indian billionaire and promoted by sportspersons, has drawn skepticism from medical professionals who allege its claims are exaggerated.

    This reported criticism from doctors highlights a common challenge in health technology: the distinction between a device's advertised function and its verifiable scientific basis. For tools designed to monitor internal physiological processes like brain blood flow, the accuracy and reliability of measurements are critical. When medical experts question the claims, it raises concerns about the rigor of the underlying science and the evidence supporting the device's stated benefits.

    The situation with Temple illustrates how commercial promotion of innovative health wearables can outpace widespread medical consensus on their efficacy. While consumer interest in personal health monitoring is high, the medical community typically requires robust, independently verifiable data to endorse such tools for health-related insights. The current debate suggests a potential gap between the device's marketing and its clinical validation.

    Share this article

    Original reporting by New Straits TimesWe don't republish, read the full story â†’

    Related reading

    6 stories